117 related articles for article (PubMed ID: 38537563)
1. Applying image features of proximal paracancerous tissues in predicting prognosis of patients with hepatocellular carcinoma.
Lin S; Yong J; Zhang L; Chen X; Qiao L; Pan W; Yang Y; Zhao H
Comput Biol Med; 2024 May; 173():108365. PubMed ID: 38537563
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.
Li P; Ma X; Huang D; Gu X
Int J Immunopathol Pharmacol; 2023; 37():3946320231218179. PubMed ID: 38054921
[No Abstract] [Full Text] [Related]
3. Recurrence risk stratification of hepatocellular carcinomas based on immune gene expression and features extracted from pathological images.
Ding T; Li X; Mo J; Alexander G; Li J
PLoS Comput Biol; 2023 Dec; 19(12):e1011716. PubMed ID: 38157378
[TBL] [Abstract][Full Text] [Related]
4. A novel deep learning-based algorithm combining histopathological features with tissue areas to predict colorectal cancer survival from whole-slide images.
Li YJ; Chou HH; Lin PC; Shen MR; Hsieh SY
J Transl Med; 2023 Oct; 21(1):731. PubMed ID: 37848862
[TBL] [Abstract][Full Text] [Related]
5. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
[TBL] [Abstract][Full Text] [Related]
6. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
7. Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images.
Chen Q; Xiao H; Gu Y; Weng Z; Wei L; Li B; Liao B; Li J; Lin J; Hei M; Peng S; Wang W; Kuang M; Chen S
Hepatol Int; 2022 Jun; 16(3):590-602. PubMed ID: 35349075
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
9. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
Wang S; Bai H; Fei S; Miao B
Biochem Genet; 2023 Oct; ():. PubMed ID: 37898914
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor-infiltrating B cells in the tumor microenvironment of hepatocellular carcinoma and its prognostic value: a bioinformatics analysis.
Zou J; Luo C; Xin H; Xue T; Xie X; Chen R; Zhang L
J Gastrointest Oncol; 2022 Aug; 13(4):1959-1966. PubMed ID: 36092319
[TBL] [Abstract][Full Text] [Related]
13. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
14. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
15. An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma.
Yao N; Jiang W; Wang Y; Song Q; Cao X; Zheng W; Zhang J
Eur J Med Res; 2023 Mar; 28(1):123. PubMed ID: 36918943
[TBL] [Abstract][Full Text] [Related]
16. Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma.
Shen B; Zhang G; Liu Y; Wang J; Jiang J
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292719
[TBL] [Abstract][Full Text] [Related]
17. LiverNet: efficient and robust deep learning model for automatic diagnosis of sub-types of liver hepatocellular carcinoma cancer from H&E stained liver histopathology images.
Aatresh AA; Alabhya K; Lal S; Kini J; Saxena PUP
Int J Comput Assist Radiol Surg; 2021 Sep; 16(9):1549-1563. PubMed ID: 34053009
[TBL] [Abstract][Full Text] [Related]
18. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
Zhao M; Shen S; Xue C
Front Immunol; 2022; 13():805967. PubMed ID: 35401564
[TBL] [Abstract][Full Text] [Related]
19. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
20. Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas.
Ding F; Li J; Zhang Y; Wang C; Yu Y
Oxid Med Cell Longev; 2022; 2022():8248355. PubMed ID: 35915607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
